List of Excipients in API famotidine, calcium carbonate, and magnesium hydroxide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing famotidine, calcium carbonate, and magnesium hydroxide
Detailed excipient profiles for famotidine, calcium carbonate, and magnesium hydroxide
Excipient focus: ACACIA
famotidine, calcium carbonate, and magnesium hydroxide drug variants containing ACACIA
famotidine, calcium carbonate, and magnesium hydroxide drug variants not containing ACACIA
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ALUMINUM OXIDE
famotidine, calcium carbonate, and magnesium hydroxide drug variants containing ALUMINUM OXIDE
famotidine, calcium carbonate, and magnesium hydroxide drug variants not containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Johnson & Johnson Consumer Inc | famotidine, calcium carbonate, and magnesium hydroxide | 16837-891 |
| R J General Corporation | famotidine, calcium carbonate, and magnesium hydroxide | 70264-034 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE ACETATE
famotidine, calcium carbonate, and magnesium hydroxide drug variants containing CELLULOSE ACETATE
famotidine, calcium carbonate, and magnesium hydroxide drug variants not containing CELLULOSE ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CORN SYRUP
famotidine, calcium carbonate, and magnesium hydroxide drug variants containing CORN SYRUP
| Company | Ingredient | NDC |
|---|---|---|
| Johnson & Johnson Consumer Inc | famotidine, calcium carbonate, and magnesium hydroxide | 16837-246 |
| Select Corporation | famotidine, calcium carbonate, and magnesium hydroxide | 52904-948 |
| >Company | >Ingredient | >NDC |
famotidine, calcium carbonate, and magnesium hydroxide drug variants not containing CORN SYRUP
Excipient focus: CROSPOVIDONE
famotidine, calcium carbonate, and magnesium hydroxide drug variants containing CROSPOVIDONE
famotidine, calcium carbonate, and magnesium hydroxide drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 7
famotidine, calcium carbonate, and magnesium hydroxide drug variants containing D&C RED NO. 7
famotidine, calcium carbonate, and magnesium hydroxide drug variants not containing D&C RED NO. 7
Excipient focus: DEXTROSE
famotidine, calcium carbonate, and magnesium hydroxide drug variants containing DEXTROSE
famotidine, calcium carbonate, and magnesium hydroxide drug variants not containing DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
famotidine, calcium carbonate, and magnesium hydroxide drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Navajo Manufacturing Company Inc | famotidine, calcium carbonate, and magnesium hydroxide | 67751-202 |
| >Company | >Ingredient | >NDC |
famotidine, calcium carbonate, and magnesium hydroxide drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
famotidine, calcium carbonate, and magnesium hydroxide drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
famotidine, calcium carbonate, and magnesium hydroxide drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
Excipient focus: FD&C RED NO. 3
famotidine, calcium carbonate, and magnesium hydroxide drug variants containing FD&C RED NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| R J General Corporation | famotidine, calcium carbonate, and magnesium hydroxide | 70264-034 |
| >Company | >Ingredient | >NDC |
famotidine, calcium carbonate, and magnesium hydroxide drug variants not containing FD&C RED NO. 3
Excipient focus: FD&C RED NO. 40
famotidine, calcium carbonate, and magnesium hydroxide drug variants containing FD&C RED NO. 40
famotidine, calcium carbonate, and magnesium hydroxide drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 5
famotidine, calcium carbonate, and magnesium hydroxide drug variants containing FD&C YELLOW NO. 5
| Company | Ingredient | NDC |
|---|---|---|
| Johnson & Johnson Consumer Inc | famotidine, calcium carbonate, and magnesium hydroxide | 16837-246 |
| Select Corporation | famotidine, calcium carbonate, and magnesium hydroxide | 52904-948 |
| >Company | >Ingredient | >NDC |
famotidine, calcium carbonate, and magnesium hydroxide drug variants not containing FD&C YELLOW NO. 5
Excipient focus: FD&C YELLOW NO. 6
famotidine, calcium carbonate, and magnesium hydroxide drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Johnson & Johnson Consumer Inc | famotidine, calcium carbonate, and magnesium hydroxide | 16837-246 |
| Select Corporation | famotidine, calcium carbonate, and magnesium hydroxide | 52904-948 |
| >Company | >Ingredient | >NDC |
famotidine, calcium carbonate, and magnesium hydroxide drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE YELLOW
famotidine, calcium carbonate, and magnesium hydroxide drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Johnson & Johnson Consumer Inc | famotidine, calcium carbonate, and magnesium hydroxide | 16837-891 |
| >Company | >Ingredient | >NDC |
famotidine, calcium carbonate, and magnesium hydroxide drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: HYDROXYPROPYL CELLULOSE
famotidine, calcium carbonate, and magnesium hydroxide drug variants containing HYDROXYPROPYL CELLULOSE
famotidine, calcium carbonate, and magnesium hydroxide drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
famotidine, calcium carbonate, and magnesium hydroxide drug variants containing HYPROMELLOSE
famotidine, calcium carbonate, and magnesium hydroxide drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
famotidine, calcium carbonate, and magnesium hydroxide drug variants containing LACTOSE MONOHYDRATE
famotidine, calcium carbonate, and magnesium hydroxide drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
famotidine, calcium carbonate, and magnesium hydroxide drug variants containing MAGNESIUM STEARATE
famotidine, calcium carbonate, and magnesium hydroxide drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
famotidine, calcium carbonate, and magnesium hydroxide drug variants containing MALTODEXTRIN
famotidine, calcium carbonate, and magnesium hydroxide drug variants not containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MINERAL OIL
famotidine, calcium carbonate, and magnesium hydroxide drug variants containing MINERAL OIL
famotidine, calcium carbonate, and magnesium hydroxide drug variants not containing MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
famotidine, calcium carbonate, and magnesium hydroxide drug variants containing STARCH, CORN
famotidine, calcium carbonate, and magnesium hydroxide drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
famotidine, calcium carbonate, and magnesium hydroxide drug variants containing SUCRALOSE
famotidine, calcium carbonate, and magnesium hydroxide drug variants not containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
famotidine, calcium carbonate, and magnesium hydroxide drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Johnson & Johnson Consumer Inc | famotidine, calcium carbonate, and magnesium hydroxide | 16837-246 |
| Select Corporation | famotidine, calcium carbonate, and magnesium hydroxide | 52904-948 |
| >Company | >Ingredient | >NDC |
famotidine, calcium carbonate, and magnesium hydroxide drug variants not containing TRIACETIN
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
